PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.

Cerebral malaria (CM) is associated with a high mortality rate, and long-term neurocognitive impairment in approximately one third of survivors. Adjunctive therapies that modify the pathophysiological processes involved in CM may improve outcome over anti-malarial therapy alone. PPARγ agonists have...

Full description

Saved in:
Bibliographic Details
Main Authors: Lena Serghides, Chloe R McDonald, Ziyue Lu, Miriam Friedel, Cheryl Cui, Keith T Ho, Howard T J Mount, John G Sled, Kevin C Kain
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2014
Subjects:
Online Access:https://doaj.org/article/2c2aeaa0ad1a4561bcd0a02d50ccfbe5
Tags: Add Tag
No Tags, Be the first to tag this record!